This inventor holds 2 USPTO granted patents. Top assignees: Consorzio Per La Gestione Del Centro Di Biotecnologie Avanzate, Istituto Nazionale Per La Ricerca Sul Cancro, Other. Active years: 2003-2006.
Company Filing History:
1 out of 1 
1 out of 3 
1 out of 834,453 Years Active: 2003-2006
Title: Beatrice Dozin: Innovator in Stem Cell Research
Introduction
Beatrice Dozin is a prominent inventor based in Rapallo, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of serum-free media for stem cell growth. With a total of 2 patents, her work has the potential to advance regenerative medicine and tissue engineering.
Latest Patents
Dozin's latest patents focus on serum-free media for the growth and proliferation of chondrocytes and mesenchymal stem cells. One of her patents describes a serum-free medium that includes a composition comprising FGF-2, linoleic acid, ascorbic acid, B-mercaptoethanol, transferrin, and dexamethasone. This innovative medium also incorporates EGF, PDGFbb, insulin, and albumin, providing a comprehensive solution for growing chondrocytes in culture. Additionally, she has developed a serum-free medium specifically for mesenchymal stem cell growth, which includes FGF-2, LIF, SCF, pantotenate, biotin, and selenium.
Career Highlights
Throughout her career, Beatrice Dozin has worked with various organizations, including the Consorzio per la Gestione del Centro di Biotecnologie Avanzate. Her expertise in biotechnology has positioned her as a key figure in the advancement of stem cell research.
Collaborations
Dozin has collaborated with notable professionals in her field, including her coworker Ranieri Cancedda. Their joint efforts have contributed to the development of innovative solutions in biotechnology.
Conclusion
Beatrice Dozin's work in developing serum-free media for stem cell growth showcases her dedication to advancing biotechnology. Her patents reflect her innovative spirit and commitment to improving regenerative medicine.